Back to Market Feed

Historical record - last NADAC effective date: 7/17/2024

Product Information

PHENTERMINE 37.5 MG CAPSULE is a generic product labeled by Sunrise Pharmaceutical Inc., priced at $0.0814 per EA under NDC 11534015930. Its NADAC has been published 275 times since May 15, 2019.

FDA first approved this application on Sep 25, 2014. Its Orange Book therapeutic-equivalence code is AA.

PHENTERMINE 37.5 MG CAPSULE

phentermine hydrochloride
$0.0814per EA
DEA Schedule CIV

Strength

37.5 mg/1

NDC

11534015930

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

7/17/2024

Active Ingredients

PHENTERMINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA205017

FDA Approved

9/25/2014

TE Code

AA

On Market Since

1/24/2017

Pharmacological Classes

Appetite Suppression
Increased Sympathetic Activity
Sympathomimetic Amine Anorectic

Price Statistics

The NADAC for PHENTERMINE 37.5 MG CAPSULE has been published 275 times since May 15, 2019, and over the history we have for it it has declined 27.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0814 per EA
All-time high$0.1421 (Apr 10, 2024)
All-time low$0.0688 (Dec 23, 2020)
Median price$0.1005
Average price$0.1017
Largest weekly change+64.3% (Nov 22, 2023)
Weeks tracked275
Tracking sinceMay 15, 2019

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

-26.5%

5Y

-14.0%

All

-27.7%

Last surveyed Aug 14, 2024 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the phentermine hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

NASAL SPRAY 0.05%
Generic
36800030410•Topco Associates LLC
$0.0625
per ML
NASAL SPRAY 0.05%
Generic
36800081710•Topco Associates LLC
$0.0625
per ML
NASAL DECONGESTANT 0.05% SPRAY
Generic
51672203005•Taro Pharmaceuticals U.S.A. Inc.
$0.0625
per ML
NASAL DECONGESTANT 0.05% SPRAY
Generic
51672203003•Taro Pharmaceuticals U.S.A. Inc.
$0.0678
per ML
PHENTERMINE 37.5 MG TABLET
Generic
51224010150•TAGI Pharma Inc.
$0.0697
per EA
PHENTERMINE 37.5 MG TABLET
Generic
10702002501•KVK-Tech Inc.
$0.0708
per EA
PHENTERMINE 37.5 MG TABLET
Generic
10702002510•KVK-Tech Inc.
$0.0708
per EA
PHENTERMINE 37.5 MG TABLET
Generic
43547040410•Solco Healthcare US LLC
$0.0708
per EA
PHENTERMINE 37.5 MG TABLET
Generic
43547040411•Solco Healthcare US LLC
$0.0708
per EA
PHENTERMINE 37.5 MG TABLET
Generic
53489067601•Sun Pharmaceutical Industries Inc.
$0.0708
per EA

Frequently asked questions

What is the NADAC price of PHENTERMINE 37.5 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for PHENTERMINE 37.5 MG CAPSULE, manufactured by Sunrise Pharmaceutical Inc., is $0.0814 per EA (NDC 11534015930), effective Aug 14, 2024.

How has the price of PHENTERMINE 37.5 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for PHENTERMINE 37.5 MG CAPSULE has declined 27.7%. It has been tracked across 275 weekly CMS publications since May 15, 2019.

What are the highest and lowest recorded NADAC prices for PHENTERMINE 37.5 MG CAPSULE?

Since May 15, 2019, the NADAC for PHENTERMINE 37.5 MG CAPSULE has ranged from a low of $0.0688 (Dec 23, 2020) to a high of $0.1421 (Apr 10, 2024), with a median of $0.1005 per EA.

Are there cheaper alternatives to PHENTERMINE 37.5 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of PHENTERMINE 37.5 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures PHENTERMINE 37.5 MG CAPSULE?

PHENTERMINE 37.5 MG CAPSULE (NDC 11534015930) is labeled by Sunrise Pharmaceutical Inc., and CMS classifies it as a generic product.